Suppr超能文献

锰福地匹三钠增强MRI用于检测和鉴别肝脏局灶性病变:延迟成像是否有用?

Mangafodipir trisodium-enhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful?

作者信息

Chung Jae-Joon, Kim Myeong-Jin, Kim Ki Whang

机构信息

Department of Diagnostic Radiology and Research Institute of Radiological Science, Yonsei University College of Medicine, Seoul, Korea.

出版信息

J Magn Reson Imaging. 2006 May;23(5):706-11. doi: 10.1002/jmri.20557.

Abstract

PURPOSE

To investigate the usefulness of early and delayed hepatic MRI after mangafodipir trisodium (Mn-DPDP) administration for the detection and characterization of focal hepatic lesions.

MATERIALS AND METHODS

Forty-five patients (31 males and 14 females, mean age = 61 years) with a total of 113 hepatic lesions (mean size = 3.5 cm) were included in this study (15 with hepatocellular carcinoma (HCC, N = 35), 20 with hepatic metastasis (N = 63), five with hemangioma (N = 10), three with cholangiocarcinoma (CC, N = 3), and two with liver abscess (N = 2)). T1-weighted gradient-echo MR images were obtained before and after Mn-DPDP administration, with a mean 18-hour delayed imaging. A qualitative analysis (including the size and signal intensity (SI)) and quantitative analysis (including enhancement and lesion-liver contrast-to-noise ratio (CNR)) were performed on pre- and postcontrast early and delayed MR images.

RESULTS

Compared to postcontrast early imaging, 17 (48.6%) of 35 HCCs showed higher SI, 16 (45.7%) showed no SI change, and two (5.7%) showed lower SI on delayed imaging. All 63 metastases, 10 hemangiomas, three CCs, and two abscesses showed no SI change. On delayed imaging, ring enhancement was noted in 53 metastases (84.1%), three hemangiomas (30.0%), and one abscess (50.0%), but was not seen in HCCs or CCs. Eight metastases (12.7%) also showed ring enhancement on postcontrast early imaging. No newly detected hepatic lesions were revealed on postcontrast delayed MR images compared to postcontrast early images. Regarding CNR, the HCCs showed a significant increase in CNR from postcontrast early to delayed images after administration of Mn-DPDP (P < 0.01). However, none of the metastases, hemangiomas, CCs, and abscesses showed a significant increase of CNR from postcontrast early to delayed images.

CONCLUSION

Postcontrast delayed MR images after Mn-DPDP administration were helpful in distinguishing hepatocellular from nonhepatocellular lesions, but were not useful for lesion detection and had limited utility for lesion characterization, since benign and malignant hepatic lesions looked the same.

摘要

目的

探讨静脉注射锰福地匹三钠(Mn-DPDP)后早期及延迟肝脏磁共振成像(MRI)在肝脏局灶性病变检测及特征分析中的应用价值。

材料与方法

本研究纳入45例患者(男性31例,女性14例,平均年龄61岁),共113个肝脏病变(平均大小3.5 cm),其中肝细胞癌(HCC,15例,共35个病灶)、肝转移瘤(20例,共63个病灶)、血管瘤(5例,共10个病灶)、胆管癌(3例,共3个病灶)、肝脓肿(2例,共2个病灶)。于注射Mn-DPDP前及注射后平均延迟18小时行T1加权梯度回波序列MRI检查。对增强前、增强早期及延迟期MRI图像进行定性分析(包括大小及信号强度(SI))和定量分析(包括强化程度及病灶-肝脏对比噪声比(CNR))。

结果

与增强早期图像相比,35个HCC中17个(48.6%)在延迟期图像上表现为SI升高,16个(45.7%)SI无变化,2个(5.7%)SI降低。63个转移瘤、10个血管瘤、3个胆管癌及2个肝脓肿在延迟期图像上SI均无变化。延迟期图像上,53个转移瘤(84.1%)、3个血管瘤(30.0%)及1个肝脓肿(50.0%)可见环形强化,HCC及胆管癌未见环形强化。8个转移瘤(12.7%)在增强早期图像上也可见环形强化。与增强早期图像相比,延迟期MRI图像未发现新的肝脏病变。关于CNR,HCC在注射Mn-DPDP后增强早期至延迟期图像上CNR显著升高(P < 0.01)。然而,转移瘤、血管瘤、胆管癌及肝脓肿在增强早期至延迟期图像上CNR均无显著升高。

结论

注射Mn-DPDP后延迟期MRI图像有助于肝细胞性病变与非肝细胞性病变的鉴别,但对病变检测无帮助,且在病变特征分析方面作用有限,因为良性和恶性肝脏病变表现相似。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验